JEW
ZBH icon

Jamison Eaton & Wood’s Zimmer Biomet ZBH Stock Holding History

Jamison Eaton & Wood’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-206
Closed -$16K – 213
2013
Q3 		$16K Buy
+206
New +$16.2K ﹤0.01% 218

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jamison Eaton & Wood's ZBH Position: Q4 2013 in Review

Jamison Eaton & Wood sold out of Zimmer Biomet (ZBH) in Q4 2013, closing a stake of 206 shares — an estimated $16K sold.

Jamison Eaton & Wood first reported a position in ZBH in Q3 2013 and held it in 1 quarter. The position peaked at $16K in Q3 2013. 694 funds tracked by Wall St. Rank hold ZBH as of Q4 2013.

  • Jamison Eaton & Wood reported no remaining Zimmer Biomet position as of Q4 2013 after selling out during the quarter.
  • Jamison Eaton & Wood sold 206 Zimmer Biomet shares in Q4 2013, an estimated $16K.
  • Jamison Eaton & Wood first reported a position in Zimmer Biomet in Q3 2013 and held it in 1 quarter.
  • Jamison Eaton & Wood's Zimmer Biomet position peaked at $16K in Q3 2013.
  • 694 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2013.

Based on Jamison Eaton & Wood's 13F filing for Q4 2013, filed 11 Feb 2014.